A Unique and Specific Interaction Between Αt-Catenin and Plakophilin
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Wiskott-Aldrich Syndrome: the Actin Cytoskeleton and Immune Cell Function
Disease Markers 29 (2010) 157–175 157 DOI 10.3233/DMA-2010-0735 IOS Press The Wiskott-Aldrich syndrome: The actin cytoskeleton and immune cell function Michael P. Blundella, Austen Wortha,b, Gerben Boumaa and Adrian J. Thrashera,b,∗ aMolecular Immunology Unit, UCL Institute of Child Health, London, UK bDepartment of Immunology, Great Ormond Street Hospital NHS Trust, Great Ormond Street, London, UK Abstract. Wiskott-Aldrich syndrome (WAS) is a rare X-linked recessive primary immunodeficiency characterised by immune dysregulation, microthrombocytopaenia, eczema and lymphoid malignancies. Mutations in the WAS gene can lead to distinct syndrome variations which largely, although not exclusively, depend upon the mutation. Premature termination and deletions abrogate Wiskott-Aldrich syndrome protein (WASp) expression and lead to severe disease (WAS). Missense mutations usually result in reduced protein expression and the phenotypically milder X-linked thrombocytopenia (XLT) or attenuated WAS [1–3]. More recently however novel activating mutations have been described that give rise to X-linked neutropenia (XLN), a third syndrome defined by neutropenia with variable myelodysplasia [4–6]. WASP is key in transducing signals from the cell surface to the actin cytoskeleton, and a lack of WASp results in cytoskeletal defects that compromise multiple aspects of normal cellular activity including proliferation, phagocytosis, immune synapse formation, adhesion and directed migration. Keywords: Wiskott-Aldrich syndrome, actin polymerization, lymphocytes, -
Loss of At-Catenin Alters the Hybrid Adhering Junctions in the Heart and Leads to Dilated Cardiomyopathy and Ventricular Arrhythmia Following Acute Ischemia
1058 Research Article Loss of aT-catenin alters the hybrid adhering junctions in the heart and leads to dilated cardiomyopathy and ventricular arrhythmia following acute ischemia Jifen Li1,*, Steven Goossens2,3,`, Jolanda van Hengel2,3,`, Erhe Gao1, Lan Cheng1, Koen Tyberghein2,3, Xiying Shang1, Riet De Rycke2, Frans van Roy2,3,* and Glenn L. Radice1 1Center for Translational Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USA 2Department for Molecular Biomedical Research, Flanders Institute for Biotechnology (VIB), B-9052 Ghent, Belgium 3Department of Biomedical Molecular Biology, Ghent University, B-9052 Ghent, Belgium *Authors for correspondence ([email protected]; [email protected]) `These authors contributed equally to this work Accepted 4 October 2011 Journal of Cell Science 125, 1058–1067 ß 2012. Published by The Company of Biologists Ltd doi: 10.1242/jcs.098640 Summary It is generally accepted that the intercalated disc (ICD) required for mechano-electrical coupling in the heart consists of three distinct junctional complexes: adherens junctions, desmosomes and gap junctions. However, recent morphological and molecular data indicate a mixing of adherens junctional and desmosomal components, resulting in a ‘hybrid adhering junction’ or ‘area composita’. The a-catenin family member aT-catenin, part of the N-cadherin–catenin adhesion complex in the heart, is the only a-catenin that interacts with the desmosomal protein plakophilin-2 (PKP2). Thus, it has been postulated that aT-catenin might serve as a molecular integrator of the two adhesion complexes in the area composita. To investigate the role of aT-catenin in the heart, gene targeting technology was used to delete the Ctnna3 gene, encoding aT-catenin, in the mouse. -
Vinculin Antibody Cat
Vinculin Antibody Cat. No.: 7809 Vinculin Antibody Figure 2 Western Blot Validation in Human, Mouse and Rat Cell Lines Figure 3 Western Blot Validation in PC3 Cell Lysate Loading: 15 μg of lysates per lane. Antibodies: Vinculin Loading: 15 μg of lysates per lane. Antibodies: Vinculin 7809 (1 μg/mL), 1h incubation at RT in 5% NFDM/TBST. 7809 (Lane 1: 0.5 μg/mL and Lane 2: 1 μg/mL), 1h Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 incubation at RT in 5% NFDM/TBST. Secondary: Goat anti- dilution. rabbit IgG HRP conjugate at 1:10000 dilution. Figure 4 Immunocytochemistry Validation of Vinculin in Jurkat Cells Figure 5 Immunofluorescence Validation of Vinculin in Immunocytochemical analysis of Jurkat cells using anti- Jurkat Cells Vinculin antibody (7809) at 5 μg/ml. Cells was fixed with Immunofluorescent analysis of 4% paraformaldehyde- formaldehyde and blocked with 10% serum for 1 h at RT; fixed Jurkat cells labeling Vinculin with 7809 at 20 μg/mL, antigen retrieval was by heat mediation with a citrate followed by goat anti-rabbit IgG secondary antibody at buffer (pH6). Samples were incubated with primary 1/500 dilution (green) and DAPI staining (blue). antibody overnight at 4˚C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin. Specifications September 23, 2021 1 https://www.prosci-inc.com/vinculin-antibody-7809.html HOST SPECIES: Rabbit SPECIES REACTIVITY: Human, Mouse, Rat HOMOLOGY: Predicted species reactivity based on immunogen sequence: Pig: (100%) Anti-Vinculin antibody (7809) was raised against a peptide corresponding to 23 amino IMMUNOGEN: acids near the center of human Vinculin. -
Genes in Eyecare Geneseyedoc 3 W.M
Genes in Eyecare geneseyedoc 3 W.M. Lyle and T.D. Williams 15 Mar 04 This information has been gathered from several sources; however, the principal source is V. A. McKusick’s Mendelian Inheritance in Man on CD-ROM. Baltimore, Johns Hopkins University Press, 1998. Other sources include McKusick’s, Mendelian Inheritance in Man. Catalogs of Human Genes and Genetic Disorders. Baltimore. Johns Hopkins University Press 1998 (12th edition). http://www.ncbi.nlm.nih.gov/Omim See also S.P.Daiger, L.S. Sullivan, and B.J.F. Rossiter Ret Net http://www.sph.uth.tmc.edu/Retnet disease.htm/. Also E.I. Traboulsi’s, Genetic Diseases of the Eye, New York, Oxford University Press, 1998. And Genetics in Primary Eyecare and Clinical Medicine by M.R. Seashore and R.S.Wappner, Appleton and Lange 1996. M. Ridley’s book Genome published in 2000 by Perennial provides additional information. Ridley estimates that we have 60,000 to 80,000 genes. See also R.M. Henig’s book The Monk in the Garden: The Lost and Found Genius of Gregor Mendel, published by Houghton Mifflin in 2001 which tells about the Father of Genetics. The 3rd edition of F. H. Roy’s book Ocular Syndromes and Systemic Diseases published by Lippincott Williams & Wilkins in 2002 facilitates differential diagnosis. Additional information is provided in D. Pavan-Langston’s Manual of Ocular Diagnosis and Therapy (5th edition) published by Lippincott Williams & Wilkins in 2002. M.A. Foote wrote Basic Human Genetics for Medical Writers in the AMWA Journal 2002;17:7-17. A compilation such as this might suggest that one gene = one disease. -
Conditional Ablation of P130cas/BCAR1 Adaptor Protein
Camacho Leal et al. Cell Communication and Signaling (2018) 16:73 https://doi.org/10.1186/s12964-018-0289-z RESEARCH Open Access Conditional ablation of p130Cas/BCAR1 adaptor protein impairs epidermal homeostasis by altering cell adhesion and differentiation Maria del Pilar Camacho Leal†, Andrea Costamagna†, Beatrice Tassone, Stefania Saoncella, Matilde Simoni, Dora Natalini, Aurora Dadone, Marianna Sciortino, Emilia Turco, Paola Defilippi, Enzo Calautti‡ and Sara Cabodi*‡ Abstract Background: p130 Crk-associated substrate (p130CAS; also known as BCAR1) is a scaffold protein that modulates many essential cellular processes such as cell adhesion, proliferation, survival, cell migration, and intracellular signaling. p130Cas has been shown to be highly expressed in a variety of human cancers of epithelial origin. However, few data are available regarding the role of p130Cas during normal epithelial development and homeostasis. Methods: To this end, we have generated a genetically modified mouse in which p130Cas protein was specifically ablated in the epidermal tissue. Results: By using this murine model, we show that p130Cas loss results in increased cell proliferation and reduction of cell adhesion to extracellular matrix. In addition, epidermal deletion of p130Cas protein leads to premature expression of “late” epidermal differentiation markers, altered membrane E-cadherin/catenin proteins localization and aberrant tyrosine phosphorylation of E-cadherin/catenin complexes. Interestingly, these alterations in adhesive properties in absence -
Catenin Controls Vinculin Binding
ARTICLE Received 4 Feb 2014 | Accepted 25 Jun 2014 | Published 31 Jul 2014 DOI: 10.1038/ncomms5525 Force-dependent conformational switch of a-catenin controls vinculin binding Mingxi Yao1,*, Wu Qiu2,3,*, Ruchuan Liu2,3, Artem K. Efremov1, Peiwen Cong1,4, Rima Seddiki5, Manon Payre5, Chwee Teck Lim1,6, Benoit Ladoux1,5,Rene´-Marc Me`ge5 & Jie Yan1,3,6,7 Force sensing at cadherin-mediated adhesions is critical for their proper function. a-Catenin, which links cadherins to actomyosin, has a crucial role in this mechanosensing process. It has been hypothesized that force promotes vinculin binding, although this has never been demonstrated. X-ray structure further suggests that a-catenin adopts a stable auto-inhibitory conformation that makes the vinculin-binding site inaccessible. Here, by stretching single a- catenin molecules using magnetic tweezers, we show that the subdomains MI vinculin- binding domain (VBD) to MIII unfold in three characteristic steps: a reversible step at B5pN and two non-equilibrium steps at 10–15 pN. 5 pN unfolding forces trigger vinculin binding to the MI domain in a 1:1 ratio with nanomolar affinity, preventing MI domain refolding after force is released. Our findings demonstrate that physiologically relevant forces reversibly unfurl a- catenin, activating vinculin binding, which then stabilizes a-catenin in its open conformation, transforming force into a sustainable biochemical signal. 1 Mechanobiology Institute, National University of Singapore, Singapore 117411, Singapore. 2 Department of Physics, National University of Singapore, Singapore 117542, Singapore. 3 College of Physics, Chongqing University, No. 55 Daxuecheng South Road, Chongqing 401331, China. 4 Singapore-MIT Alliance for Research and Technology, National University of Singapore, Singapore 117543, Singapore. -
Differential Stromal Reprogramming in Benign and Malignant Naturally Occurring Canine Mammary Tumours Identifies Disease-Promoting Stromal Components
bioRxiv preprint doi: https://doi.org/10.1101/783621; this version posted September 26, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Differential stromal reprogramming in benign and malignant naturally occurring canine mammary tumours identifies disease-promoting stromal components Parisa Amini 1,a, Sina Nassiri 2,a, Alexandra Malbon 3,4 and Enni Markkanen 1,* 1 Institute of Veterinary Pharmacology and Toxicology, Vetsuisse Faculty, University of Zürich, Zürich, Switzerland 2 Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland 3 Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zürich, Zürich, Switzerland 4 current address: The Royal (Dick) School of Veterinary Studies and The Roslin Institute Easter Bush Campus, Midlothian, EH25 9RG a these authors contributed equally to the manuscript * Correspondence: [email protected]; ORCID: 0000-0001-7780-8233 Keywords Laser-capture microdissection, canine mammary carcinoma, canine mammary adenoma, breast cancer, tumour stroma, tumour microenvironment Summary statement: RNasequencing-based analysis of stromal reprogramming between benign and malignant naturally occurring canine mammary tumours identifies potential molecular drivers in cancer-associated stroma that support tumour growth and malignancy. Abstract The importance of cancer-associated stroma (CaS) for initiation and progression of cancer is well accepted. However, as stromal changes in benign forms of naturally occurring tumours are poorly understood, it remains unclear how CaS from benign and malignant tumours compare. Spontaneous canine mammary tumours are viewed as excellent models of human mammary carcinomas (mCa). -
Altered Distribution of ß-Catenin, and Its Binding Proteins E-Cadherin And
Altered Distribution of -Catenin, and Its Binding Proteins E-Cadherin and APC, in Ulcerative Colitis–Related Colorectal Cancers Daniela E. Aust, M.D., Jonathan P. Terdiman, M.D., Robert F. Willenbucher, M.D., Karen Chew, C.T. (A.S.C.P.), Linda Ferrell, M.D., Carmina Florendo, B.S., Annette Molinaro-Clark, M.A., Gustavo B. Baretton, M.D., Ph.D, Udo Löhrs, M.D., Ph.D, Frederic M. Waldman, M.D., Ph.D Cancer Center (DA, KC, CF, AC, FW) and Departments of Laboratory Medicine (FW), Medicine (RW, JT), and Pathology (LF), University of California San Francisco, San Francisco, California; and Pathologisches Institut der Ludwig-Maximilians-Universität, München, Germany (GB, UL) related and sporadic colorectal cancers suggest that The -catenin pathway plays a central role in tran- the specific alterations in this pathway may differ in scriptional signaling and cell–cell interactions in these two cancer groups. colonic epithelium. Alterations of the expression of -catenin, and its binding partners E-cadherin and KEY WORDS: APC, -catenin, Colorectal cancer, the adenomatous polyposis coli protein (APC), are E-cadherin, Immunohistochemistry, Ulcerative frequent events in sporadic colorectal cancer. Ulcer- colitis. ative colitis (UC)–related cancers originate in a field Mod Pathol 2001;14(1):29–39 of chronic inflammation and therefore may have  different alterations in the -catenin pathway than -catenin is a multifunctional protein that is involved sporadic cancers. To test this hypothesis, expres- in cell–cell interaction and transcriptional signaling  sion and subcellular localization of -catenin, (1–5). -catenin expression is largely regulated by its E-cadherin, and APC were detected by immunohis- two major binding partners, E-cadherin on the mem- tochemistry in paraffin sections from 33 UC-related brane and the adenomatous polyposis coli (APC) and 42 sporadic colorectal cancers. -
The Role of the Interaction of the Vinculin Proline-Rich Linker Region
ß 2014. Published by The Company of Biologists Ltd | Journal of Cell Science (2014) 127, 1875–1886 doi:10.1242/jcs.133645 RESEARCH ARTICLE The role of the interaction of the vinculin proline-rich linker region with vinexin a in sensing the stiffness of the extracellular matrix Hiroshi Yamashita1,*, Takafumi Ichikawa1,*, Daisuke Matsuyama1, Yasuhisa Kimura1, Kazumitsu Ueda1,2, Susan W. Craig3, Ichiro Harada4 and Noriyuki Kioka1,` ABSTRACT information into biochemical signals. At FAs, transmembrane ECM receptors, integrins, are connected to the ends of actin stress Although extracellular matrix (ECM) stiffness is an important aspect fibers through various cytoplasmic proteins, including talin and of the extracellular microenvironment and is known to direct the vinculin. Cells sense ECM stiffness by ‘pulling’ on the ECM lineage specification of stem cells and affect cancer progression, using actomyosin-generated intracellular tension through FAs and the molecular mechanisms that sense ECM stiffness have not yet adjusting the tension that they exert accordingly (Geiger et al., been elucidated. In this study, we show that the proline-rich linker 2009; Parsons et al., 2010); cells on rigid ECM exert higher (PRL) region of vinculin and the PRL-region-binding protein vinexin intracellular tension than cells on soft ECM. Although some FA are involved in sensing the stiffness of ECM substrates. A rigid proteins have been suggested to engage in sensing intracellular substrate increases the level of cytoskeleton-associated vinculin, tension (del Rio et al., 2009; Friedland et al., 2009; Sawada et al., and the fraction of vinculin stably localizing at focal adhesions (FAs) 2006), the signaling mechanisms by which cells sense ECM is larger on rigid ECM than on soft ECM. -
The Role of the Actin Cytoskeleton During Muscle Development In
THE ROLE OF THE ACTIN CYTOSKELETON DURING MUSCLE DEVELOPMENT IN DROSOPHILA AND MOUSE by Shannon Faye Yu A Dissertation Presented to the Faculty of the Louis V. Gerstner, Jr. Graduate School of the Biomedical Sciences in Partial Fulfillment of the Requirements of the Degree of Doctor of Philosophy New York, NY Oct, 2013 Mary K. Baylies, PhD! Date Dissertation Mentor Copyright by Shannon F. Yu 2013 ABSTRACT The actin cytoskeleton is essential for many processes within a developing organism. Unsurprisingly, actin and its regulators underpin many of the critical steps in the formation and function of muscle tissue. These include cell division during the specification of muscle progenitors, myoblast fusion, muscle elongation and attachment, and muscle maturation, including sarcomere assembly. Analysis in Drosophila has focused on regulators of actin polymerization particularly during myoblast fusion, and the conservation of many of the actin regulators required for muscle development has not yet been tested. In addition, dynamic actin processes also require the depolymerization of existing actin fibers to replenish the pool of actin monomers available for polymerization. Despite this, the role of actin depolymerization has not been described in depth in Drosophila or mammalian muscle development. ! Here, we first examine the role of the actin depolymerization factor Twinstar (Tsr) in muscle development in Drosophila. We show that Twinstar, the sole Drosophila member of the ADF/cofilin family of actin depolymerization proteins, is expressed in muscle where it is essential for development. tsr mutant embryos displayed a number of muscle defects, including muscle loss and muscle misattachment. Further, regulators of Tsr, including a Tsr-inactivating kinase, Center divider, a Tsr-activating phosphatase, Slingshot and a synergistic partner in depolymerization, Flare, are also required for embryonic muscle development. -
The Relationship Between Intermediate Filaments and Microfilaments Before and During the Formation of Desmosomes and Adherens-Ty
Published May 1, 1987 The Relationship between Intermediate Filaments and Microfilaments before and during the Formation of Desmosomes and Adherens-type Junctions in Mouse Epidermal Keratinocytes Kathleen J. Green, Benjamin Geiger,* Jonathan C. R. Jones, John C. Talian, and Robert D. Goldman Department of Cell Biology and Anatomy, Northwestern University Medical School, Chicago, Illinois 60611; and * Department of Chemical Immunology, The Weizmann Institute of Science, Rehovot, Israel Abstract. Actin, keratin, vinculin and desmoplakin ermost of the concentric MFB. Individual IF often organization were studied in primary mouse keratino- splay out, becoming interwoven into these MFB in the cytes before and during Ca2+-induced cell contact forma- region of cell-substrate contact. In the first 30 min af- tion. Double-label fluorescence shows that in cells cul- ter the Ca 2+ switch, areas of submembranous dense Downloaded from tured in low Ca 2÷ medium, keratin-containing inter- material (identified as adherens junctions), which are mediate filament bundles (IFB) and desmoplakin- associated with the perpendicular MFB, can be seen at containing spots are both concentrated towards the cell newly formed cell-ceU contact sites. By 1-2 h, IFB- center in a region bounded by a series of concentric desmosomal component complexes are aligned with microfilament bundles (MFB). Within 5-30 min after the perpendicular MFB as the complexes become jcb.rupress.org raising Ca 2+ levels, a discontinuous actin/vinculin-rich, redistributed to cell-cell interfaces. Cytochalasin D submembranous zone of fluorescence appears at cell- treatment causes the redistribution of actin into numer- cell interfaces. This zone is usually associated with ous patches; keratin-containing Lr:B undergo a con- short, perpendicular MFB, which become wider and comitant redistribution, forming foci that coincide with longer with time. -
Non-Muscle Myosin 2A (NM2A): Structure, Regulation and Function
cells Review Non-Muscle Myosin 2A (NM2A): Structure, Regulation and Function Cláudia Brito 1,2 and Sandra Sousa 1,* 1 Group of Cell Biology of Bacterial Infections, i3S-Instituto de Investigação e Inovação em Saúde, IBMC, Universidade do Porto, 4200-135 Porto, Portugal; [email protected] 2 Programa Doutoral em Biologia Molecular e Celular (MCBiology), Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, 4099-002 Porto, Portugal * Correspondence: [email protected] Received: 19 May 2020; Accepted: 29 June 2020; Published: 1 July 2020 Abstract: Non-muscle myosin 2A (NM2A) is a motor cytoskeletal enzyme with crucial importance from the early stages of development until adulthood. Due to its capacity to convert chemical energy into force, NM2A powers the contraction of the actomyosin cytoskeleton, required for proper cell division, adhesion and migration, among other cellular functions. Although NM2A has been extensively studied, new findings revealed that a lot remains to be discovered concerning its spatiotemporal regulation in the intracellular environment. In recent years, new functions were attributed to NM2A and its activity was associated to a plethora of illnesses, including neurological disorders and infectious diseases. Here, we provide a concise overview on the current knowledge regarding the structure, the function and the regulation of NM2A. In addition, we recapitulate NM2A-associated diseases and discuss its potential as a therapeutic target. Keywords: non-muscle myosin 2A (NM2A); NM2A activity regulation; NM2A filament assembly; actomyosin cytoskeleton; cell migration; cell adhesion; plasma membrane blebbing 1. Superfamily of Myosins The cell cytoskeleton is an interconnected and dynamic network of filaments essential for intracellular organization and cell shape maintenance.